•
The dose-response relationship from the case-
control study estimates risk in terms of the
percentage
increase per Gy
•
It can be combined with
recent population-
based rates
of:
–
death from ischaemic heart disease
or
–
incidence of acute coronary events
•
to provide estimates of the
absolute
risks
29